1 Tang H, "miR-505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT-NFκB pathway in NSCLC cells" 43 : 1203-1216, 2019
2 Savary G, "The long noncoding RNA DNM3OS is a reservoir of fibromiRs with major functions in lung fibroblast response to TGF-β and pulmonary fibrosis" 200 : 184-198, 2019
3 Wu X, "The long non-coding RNA MALAT1 enhances ovarian cancer cell stemness by inhibiting YAP translocation from nucleus to cytoplasm" 26 : e922012-, 2020
4 Ghoneum A, "Targeting the PI3K/AKT/mTOR/NFκB axis in ovarian cancer" 2 : 68-73, 2020
5 Wang H, "SMAD6, positively regulated by the DNM3OS-miR134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma" 20 : 23-, 2020
6 Yuan D, "Role of lncRNA-ATB in ovarian cancer and its mechanisms of action" 19 : 965-971, 2020
7 Zhang Y, "Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma" 9 : 8401-, 2019
8 Zhang L, "MicroRNA-34 family : a potential tumor suppressor and therapeutic candidate in cancer" 38 : 53-, 2019
9 Lin YH, "MicroRNA networks modulate oxidative stress in cancer" 20 : 4497-, 2019
10 Chen ZM, "MiR193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1" 11 : 4825-4837, 2019
1 Tang H, "miR-505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT-NFκB pathway in NSCLC cells" 43 : 1203-1216, 2019
2 Savary G, "The long noncoding RNA DNM3OS is a reservoir of fibromiRs with major functions in lung fibroblast response to TGF-β and pulmonary fibrosis" 200 : 184-198, 2019
3 Wu X, "The long non-coding RNA MALAT1 enhances ovarian cancer cell stemness by inhibiting YAP translocation from nucleus to cytoplasm" 26 : e922012-, 2020
4 Ghoneum A, "Targeting the PI3K/AKT/mTOR/NFκB axis in ovarian cancer" 2 : 68-73, 2020
5 Wang H, "SMAD6, positively regulated by the DNM3OS-miR134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma" 20 : 23-, 2020
6 Yuan D, "Role of lncRNA-ATB in ovarian cancer and its mechanisms of action" 19 : 965-971, 2020
7 Zhang Y, "Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma" 9 : 8401-, 2019
8 Zhang L, "MicroRNA-34 family : a potential tumor suppressor and therapeutic candidate in cancer" 38 : 53-, 2019
9 Lin YH, "MicroRNA networks modulate oxidative stress in cancer" 20 : 4497-, 2019
10 Chen ZM, "MiR193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1" 11 : 4825-4837, 2019
11 Zhang L, "MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3" 12 : 875-888, 2020
12 Yin W, "MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression" 9 : 43-52, 2019
13 Chen K, "Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways" 8 : 423-436, 2018
14 Santoro R, "MEKK3 sustains EMT and stemness in pancreatic cancer by regulating YAP and TAZ transcriptional activity" 38 : 1937-1946, 2018
15 Samanta AK, "MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma" 115 : 3897-3908, 2009
16 Jia W, "MAP3K3 overexpression is associated with poor survival in ovarian carcinoma" 50 : 162-169, 2016
17 Zhou F, "Long noncoding RNA SNHG12 promotes the proliferation, migration, and invasion of trophoblast cells by regulating the epithelial-mesenchymal transition and cell cycle" 48 : 300060520922339-, 2020
18 Long X, "Long noncoding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis" 38 : 345-, 2019
19 Wang S, "Long noncoding RNA DNM3OS promotes tumor progression and EMT in gastric cancer by associating with Snail" 511 : 57-62, 2019
20 Wang R, "Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a/29b/COL3A1 and miR-361/TGFβ1 axes" 11 : 9442-9460, 2019
21 Chi Y, "Long non-coding RNA in the pathogenesis of cancers" 8 : 1015-, 2019
22 Bai Z, "Long non-coding RNA SNGH7 is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer" 24 : 7479-7489, 2020
23 Fang X, "Long non-coding RNA DNM3OS/miR-204-5p/HIP1 axis modulates oral cancer cell viability and migration" 49 : 865-875, 2020
24 Liu G, "Lnc-GIHCG promotes cell proliferation and migration in gastric cancer through miR-1281 adsorption" 7 : e711-, 2019
25 Liu H, "Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level" 24 : 1054-1061, 2020
26 Pan L, "LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR148a-3p/ROCK1 axes" 120 : 109423-, 2019
27 Hirata M, "Integrated exome and RNA sequencing of dedifferentiated liposarcoma" 10 : 5683-, 2019
28 Zhou RS, "Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue" 19 : 779-, 2019
29 Mei Z, "Histone deacetylase 6 negatively regulated microRNA-199a-5p induces the occurrence of preeclampsia by targeting VEGFA in vitro" 114 : 108805-, 2019
30 Lheureux S, "Epithelial ovarian cancer : evolution of management in the era of precision medicine" 69 : 280-304, 2019
31 Li F, "Downregulation of lncRNA NR2F2 antisense RNA 1 induces G1 arrest of colorectal cancer cells by downregulating cyclin-dependent kinase 6" 65 : 464-469, 2020
32 Mitra R, "Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition" 8 : 1604-, 2017
33 Zong ZH, "CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182" 38 : 437-, 2019
34 Zhang H, "Cancer-associated fibroblast-promoted LncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma" 25 : 1989-2000, 2019
35 Tu Z, "An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer" 36 : 215-222, 2016
36 Ding QS, "Aberrant high expression level of MORC2 is a common character in multiple cancers" 76 : 58-67, 2018